Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON

Daenen, S; van der Holt, B; Dekker, AW; Willemze, R; Rijneveld, AW; Biemond, BJ; Muus, P; van de Loosdrecht, AA; Schouten, HC; van Marwijk Kooy, M; Breems, DA; Demuynck, H; Maertens, Johan; Wijermans, PW; Wittebol, S; de Klerk, EW; Cornelissen, JJ; HOVON,; Dutch-Belgian Cooperative Group for Hematological Oncology,

doi:10.1038/leu.2012.53

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON

Author:

Daenen, S

van der Holt, B ; Dekker, AW ; Willemze, R ; Rijneveld, AW ; Biemond, BJ ; Muus, P ; van de Loosdrecht, AA ; Schouten, HC ; van Marwijk Kooy, M ; Breems, DA ; Demuynck, H ; Maertens, Johan ; Wijermans, PW ; Wittebol, S ; de Klerk, EW ; Cornelissen, JJ ; HOVON, ; Dutch-Belgian Cooperative Group for Hematological Oncology,

Keywords:

Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Feasibility Studies, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, Prospective Studies, Survival Rate, Science & Technology, Life Sciences & Biomedicine, Oncology, Hematology, STEM-CELL TRANSPLANTATION, ADULT PATIENTS, ALLOGENEIC TRANSPLANTATION, PREINDUCTION COURSE, COMPLETE REMISSION, ELDERLY-PATIENTS, 1ST, REDUCTION, REGIMEN, TRIAL, HOVON, Dutch-Belgian Cooperative Group for Hematological Oncology, 1103 Clinical Sciences, 1112 Oncology and Carcinogenesis, Immunology, 3201 Cardiovascular medicine and haematology, 3202 Clinical sciences, 3211 Oncology and carcinogenesis